MSD’s Pivotal Phase 3 C-EDGE Programme Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses AcrossBroad Range of Patients with Chronic Hepatitis C Virus Infection

Press/Media: Press / Media

PeriodApr 24 2015

Media coverage

1

Media coverage

  • TitleMSD’s Pivotal Phase 3 C-EDGE Programme Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses AcrossBroad Range of Patients with Chronic Hepatitis C Virus Infection
    Media name/outletIbero News
    CountrySpain
    Date4/24/15
    PersonsEric J Lawitz